60. Aplastic anemia Clinical trials / Disease details

Clinical trials : 245 / Drugs : 318 - (DrugBank : 86) / Drug target genes : 44 - Drug target pathways : 166

4 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01105273 (ClinicalTrials.gov)	July 2009	8/4/2010	Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Aplastic Anemia	HLA-haploidentical Allogeneic Hematopoietic Cell Transplantation Using CD3±CD19 Depletion for Patients With Aplastic Anemia After Conditioning of Fludarabine, Cyclophosphamide and Antithymocyte Globulin	Aplastic Anemia	Biological: anti-thymocyte globulin;Biological: filgrastim;Drug: Fludarabine;Drug: Cyclophosphamide;Procedure: CD3±CD19 depleted hematopoietic stem cell transplantation	Asan Medical Center	NULL	Completed	N/A	21 Years	Both	12	Phase 1/Phase 2	Korea, Republic of
2	NCT00882323 (ClinicalTrials.gov)	November 2008	15/4/2009	Reduced Toxicity Fludarabine (Flu) + Cyclophosphamide (CPM) + Rabbit Antithymocyte Globulin (rATG) Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia (SAA)	Reduced Toxicity Fludarabine, Cyclophosphamide Plus Thymoglobulin Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia	Aplastic Anemia	Drug: Cyclophosphamide , Fludarabine, Thymoglobulin	The Korean Society of Pediatric Hematology Oncology	NULL	Recruiting	1 Year	21 Years	Both	33	Phase 2	Korea, Republic of
3	NCT00737685 (ClinicalTrials.gov)	January 2006	18/8/2008	Flu+CPM+rATG Conditioning Regimes for Unrelated Bone Marrow Transplantation (UBMT)(or Mobilized Peripheral Blood)in Severe Aplastic Anemia (SAA)	Fludarabine, Cyclophosphamide Plus Thymoglobulin Conditioning Regimen for Unrelated Bone Marrow (or Mobilized Peripheral Blood) Transplantation in Severe Aplastic Anemia	Anemia, Aplastic	Drug: cyclophosphamide, fludarabine , thymoglobulin	The Korean Society of Pediatric Hematology Oncology	NULL	Active, not recruiting	N/A	25 Years	Both	30	Phase 2	Korea, Republic of
4	NCT00186797 (ClinicalTrials.gov)	December 2002	9/9/2005	Purified CD34+ Hematopoietic Stem Cell Transplantation From Alternate Donors for Patients With Severe Aplastic Anemia		Aplastic Anemia	Procedure: Allogeneic stem cell transplant;Drug: Fludarabine , Cyclophosphamide	St. Jude Children's Research Hospital	NULL	Completed	N/A	21 Years	Both	28	N/A	United States